|
|
|
Insider
Information: |
Levy Richard S |
Relationship: |
|
City: |
Wilmington |
State: |
DE |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
67,748 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,781,353 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
67,748 |
|
|
Total
Value |
$3,781,353 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
195.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
EVP, Chief Drug Dev Of... |
2016-01-06 |
16,926 |
2010-03-15 |
0 |
Premium* |
|
Madrigal Pharmaceuticals Inc |
MDGL |
|
2024-04-01 |
10,298 |
2017-08-21 |
0 |
Premium* |
|
Protara Therapeutics, Inc |
TARA |
Director |
2020-01-10 |
31,000 |
2020-01-10 |
0 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director |
2020-03-20 |
1,000 |
2020-03-20 |
0 |
Premium* |
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-05-03 |
8,524 |
2023-06-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
81 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
|
2014-09-16 |
4 |
AS |
$47.58 |
$380,640 |
D/D |
(8,000) |
4,301 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
|
2014-07-16 |
4 |
AS |
$48.15 |
$385,200 |
D/D |
(8,000) |
4,301 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
|
2014-10-16 |
4 |
AS |
$49.03 |
$392,240 |
D/D |
(8,000) |
4,301 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
|
2014-05-16 |
4 |
AS |
$50.68 |
$405,440 |
D/D |
(8,000) |
4,301 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
|
2014-08-18 |
4 |
AS |
$51.97 |
$415,760 |
D/D |
(8,000) |
4,301 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
|
2014-06-16 |
4 |
AS |
$53.88 |
$431,040 |
D/D |
(8,000) |
4,301 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
|
2014-02-14 |
4 |
S |
$66.13 |
$2,631,114 |
D/D |
(39,787) |
4,301 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
|
2014-02-13 |
4 |
S |
$66.38 |
$12,699,091 |
D/D |
(191,309) |
4,301 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
|
2014-11-17 |
4 |
AS |
$69.97 |
$839,640 |
D/D |
(12,000) |
18,205 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
|
2015-01-06 |
4 |
AS |
$71.84 |
$1,796,000 |
D/D |
(25,000) |
18,205 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
|
2014-12-16 |
4 |
AS |
$72.36 |
$868,320 |
D/D |
(12,000) |
18,205 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
|
2015-01-16 |
4 |
AS |
$73.07 |
$876,840 |
D/D |
(12,000) |
18,205 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
|
2015-02-06 |
4 |
AS |
$75.11 |
$1,877,750 |
D/D |
(25,000) |
18,205 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
|
2015-02-17 |
4 |
AS |
$76.90 |
$922,800 |
D/D |
(12,000) |
18,205 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev Officer |
|
2015-04-06 |
4 |
AS |
$88.77 |
$2,219,250 |
D/D |
(25,000) |
21,227 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev Officer |
|
2015-03-06 |
4 |
AS |
$89.91 |
$2,247,750 |
D/D |
(25,000) |
21,227 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev Officer |
|
2015-05-06 |
4 |
AS |
$99.43 |
$736,975 |
D/D |
(7,412) |
21,227 |
0 |
- |
|
MDGL |
Madrigal Pharmaceuticals ... |
Director |
|
2023-01-17 |
4 |
OE |
$100.45 |
$2,316,844 |
D/D |
22,489 |
31,589 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev Officer |
|
2016-01-06 |
4 |
AS |
$101.86 |
$401,023 |
D/D |
(3,937) |
16,926 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev Officer |
|
2015-12-07 |
4 |
AS |
$106.18 |
$418,031 |
D/D |
(3,937) |
16,926 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev Officer |
|
2015-07-06 |
4 |
AS |
$107.00 |
$421,259 |
D/D |
(3,937) |
21,227 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev Officer |
|
2015-06-08 |
4 |
AS |
$107.58 |
$423,542 |
D/D |
(3,937) |
21,227 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev Officer |
|
2015-06-19 |
4 |
AS |
$108.13 |
$2,162,600 |
D/D |
(20,000) |
21,227 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev Officer |
|
2015-08-06 |
4 |
AS |
$111.95 |
$440,635 |
D/D |
(3,936) |
21,227 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Drug Dev Officer |
|
2015-11-06 |
4 |
AS |
$116.51 |
$458,583 |
D/D |
(3,936) |
16,926 |
0 |
- |
|
81 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|